Cancer · 1998 · 60 citations · 17 references
MedicineOncologyPharmacologyChemotherapyGastrointestinal OncologyMolecular OncologyChemotherapy ResistanceGastric CancerMalignant NeoplasmsMolecular Tumor Profiling5-Fluorouracil TherapyChemoresistance In Gastric CancerGastrointestinal TumorsMedian AgeP53 AbnormalityP53 InactivationP53 MutationPrimary Tumor Characterization
BACKGROUND Inactivation of the p53 gene has been reported to be associated with resistance to chemotherapy. The authors evaluated the significance of p53 status to the clinical outcomes of patients with locally advanced, unresectable gastric carcinoma (LAGC) who received chemotherapy. METHODS Thirty chemotherapy-naive patients with LAGC received weekly administration of cisplatin 40 mg/m2, epi-doxorubicin 35 mg/m2, 5-fluorouracil 500 mg/m2, 6S-leucovorin 250 mg/m2, and glutathione 1500 mg/m2. After eight administrations of these agents, patients were assessed for response. Biopsy specimens of primary tumors were analyzed for p53 status using monoclonal antibody Bp53-12. RESULTS Characteristics of patients were as follows: The median age was 66 years (range, 44-70 years); 18 were males and 12 were females. Eastern Cooperative Oncology Group performance status was 0 for 14 patients and 1 for 16. Histology was intestinal for 13 patients; for 17, it was diffuse. The site of the primary tumor was the cardia in 8 patients, the body of the stomach in 13, and the antrum in 9. The response rate (assessed with CT scan and endoscopy) for patients with p53 negative tumors was significantly higher than for those with overexpression of p53 (71% vs. 12%, P = 0.004). CONCLUSIONS p53 status analyzed before chemotherapy seems to be associated with response to treatment in patients with LAGC. This may provide a useful guide to selecting neoadjuvant chemotherapy for these patients. Cancer 1998;83:1917-1922. © 1998 American Cancer Society.
17
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al. · Cell · 1993 · 2.9K citations
Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992
Jürgen D. Roder, K. Böttcher, J. R. Siewert et al. · Cancer · 1993 · 343 citations · Full text